Wang Meng, Zhou Ben-Gang, Zhang Yi, Ren Xi-Fang, Li Ling, Li Bo, Ai Yao-Wei
Department of Neurology, The Third Clinical Medical College of China, Three Gorges University, Gezhouba Central Hospital of Sinopharm, Yichang, China.
Department of Gastroenterology, The First People's Hospital of Yichang, The People's Hospital of China Three Gorges University, Yichang, China.
Front Cardiovasc Med. 2022 Mar 8;9:812030. doi: 10.3389/fcvm.2022.812030. eCollection 2022.
BACKGROUND/OBJECTIVES: Recent observational studies have explored the association between non-alcoholic fatty liver disease (NAFLD) and stroke with controversial results. We therefore performed a meta-analysis to investigate this possible association.
PubMed, EMBASE and Web of Science database were searched from inception until December 2019, and updated on May 2021. Random-effects meta-analyses were performed by generic inverse variance method. Subgroup and sensitivity analyses were also conducted. The PROSPERO registered number of this study is CRD42020167330.
Twenty observational (15 cohort, 4 cross-sectional, and 1 case-control) studies with 17,060,388 participants were included in the meta-analysis. Meta-analysis of data from 18 studies with 17,031,672 participants has shown that NAFLD was associated with mildly increased risk of stroke (OR = 1.18, 95% CI: 1.08-1.30, = 0.0005). Similar results were observed in most of the subgroup analyses we performed. Sensitivity analyses did not alter these findings. Meta-analysis of data from 3 studies with 29,614 participants has shown that insufficient evidence to support the proposed association between NAFLD-fibrosis and an increased risk of stroke.
We found that NAFLD was associated with increased risk of stroke. However, there was insufficient evidence to support the proposed association between NAFLD-fibrosis and an increased risk of stroke. To better understand any association, future well-designed prospective studies that take fully account of specific population, type of stroke, and confounding factors are warranted.
Unique Identifier: CRD42020167330.
背景/目的:近期的观察性研究探讨了非酒精性脂肪性肝病(NAFLD)与中风之间的关联,但结果存在争议。因此,我们进行了一项荟萃分析来研究这种可能的关联。
检索了PubMed、EMBASE和Web of Science数据库,检索时间从建库至2019年12月,并于2021年5月进行更新。采用通用逆方差法进行随机效应荟萃分析。还进行了亚组分析和敏感性分析。本研究在PROSPERO注册的编号为CRD42020167330。
荟萃分析纳入了20项观察性研究(15项队列研究、4项横断面研究和1项病例对照研究),共17,060,388名参与者。对18项研究(共17,031,672名参与者)的数据进行的荟萃分析表明,NAFLD与中风风险轻度增加相关(OR = 1.18,95%CI:1.08 - 1.30,P = 0.0005)。在我们进行的大多数亚组分析中也观察到了类似结果。敏感性分析未改变这些结果。对3项研究(共29,614名参与者)的数据进行的荟萃分析表明,没有足够的证据支持NAFLD纤维化与中风风险增加之间的关联。
我们发现NAFLD与中风风险增加相关。然而,没有足够的证据支持NAFLD纤维化与中风风险增加之间的关联。为了更好地理解任何关联,有必要开展未来设计良好的前瞻性研究,充分考虑特定人群、中风类型和混杂因素。
唯一标识符:CRD42020167330。